HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 246 filers reported holding HAEMONETICS CORP in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $65,107,414 | -0.0% | 731,602 | -3.7% | 0.09% | +2.3% |
| Q2 2023 | $65,136,021 | +18.6% | 759,592 | +14.5% | 0.09% | +15.8% |
| Q1 2023 | $54,926,266 | +33.9% | 663,664 | +28.6% | 0.08% | +38.2% |
| Q4 2022 | $41,026,145 | +81.6% | 516,224 | +72.1% | 0.06% | +66.7% |
| Q3 2022 | $22,592,000 | +11.4% | 300,014 | -2.9% | 0.03% | +17.9% |
| Q2 2022 | $20,286,000 | +6.4% | 309,020 | +1.8% | 0.03% | +21.7% |
| Q1 2022 | $19,069,000 | +19.7% | 303,525 | +1.0% | 0.02% | +21.1% |
| Q4 2021 | $15,926,000 | -25.8% | 300,588 | -1.5% | 0.02% | -29.6% |
| Q3 2021 | $21,476,000 | +5.4% | 305,209 | -0.7% | 0.03% | +3.8% |
| Q2 2021 | $20,383,000 | +1036.2% | 307,482 | +1437.0% | 0.03% | +1200.0% |
| Q2 2018 | $1,794,000 | – | 20,005 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |